I'm impressed by the ANN. A balanced spreadsheet, with increased...

I'm impressed by the ANN.

A balanced spreadsheet, with increased cost savings and plenty of juice in the tank.
Development of the CRC test program ongoing, and with commercialization success, rewards could be blue sky.
A revamped price strategy for BREVAGenplus, which will be providing many more clients access to their unique test.

And with Pippa's race shortly to come, (seriously, check her twitter feed).
GTG will be marketing the event wholeheartedly, increasing knowledge about the restructured price and availability of the test.
Surely increased revenue will come from these positive moves by management.
Tax incentive confirmation, and what more do you need to see current SP is a strong buy.